University of New Hampshire

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of New Hampshire sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 2 currently recruiting 7 completed top decile by trial count

University of New Hampshire: 10 sponsored US clinical trials, 2 recruiting.

University of New Hampshire sponsors 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Obesity, with 2 trials.

Top-decile sponsor footprint

University of New Hampshire ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

10 total, page 1 of 1

RECRUITING NA

Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities

NCT05336955
RECRUITING NA

The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults

NCT05912348
COMPLETED

Fiber-rich Foods, Weight Status, and the Gut Microbiota in NH Hispanic Adults at Risk for Food Insecurity

NCT05488912
COMPLETED

Food Environment, Food Insecurity, and Health Behaviors in NH Hispanics

NCT05424367
TERMINATED NA

Treating Adolescents With CBT and OBH

NCT04760938
COMPLETED NA

The Impact of SNAP-Ed Among Bhutanese Adults Residing in New Hampshire

NCT06445452
COMPLETED NA

Exercise & Diet Effects on CV Risk in Firefighters

NCT03344198
COMPLETED NA

Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking

NCT03488927
COMPLETED NA

Acceptance and Commitment Therapy, a Mindfulness-Based Approach for Treatment of Chronic Musculoskeletal Pain

NCT04502992
COMPLETED NA

Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative

NCT03207386

Therapeutic Areas

Obesity 2
Social Stigma 1
Drinking, College 1
Impaired Glucose Tolerance 1
Self-Criticism 1
Social Norms 1
Alcohol; Harmful Use 1
Mental Health Conditions 1
Metabolic Disturbance 1
Developmental Disability 1

What is open in the University of New Hampshire pipeline

2 recruiting of 10 indexed (20% open); 7 completed (70%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Obesity (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of New Hampshire: open-pipeline peers nationwide

Peers matched on 10 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

University of New Hampshire sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4681012 0%10%20%30%40% Total trials Recruiting share University of New HampshireAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsAcera SurgicalAlign TechnologyAltruBioAlvernia University
University of New Hampshire sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of New Hampshire sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of New Hampshire page

10 registered trials is a research-attention snapshot, not an endorsement of University of New Hampshire or any single study.

  • 2 of University of New Hampshire's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of New Hampshire studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of New Hampshire pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.